Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released ...

Medical technology company Masimo on Wednesday filed a lawsuit against U.S. Customs and Border Protection in which it challenged the agency's decision to allow Apple to restore blood oxygen monitoring ...

A federal jury in California has sided with Masimo in a patent battle with Apple over Apple Watch’s blood oxygen feature. The jury awarded Masimo $634 million in damages and concluded that Apple ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it looks like neither Masimo nor Apple are going to budge. Blood oxygen monitoring ...

Apple will bring a blood oxygen measurement feature to some of its watch models via a software update after receiving approval from the US government amid a protracted legal dispute over the ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...

On Friday (Nov. 14), Apple was hit with bad news concerning its Apple Watches from two different sources: the ongoing Masimo lawsuit and the U.S. government. The company lost a patent lawsuit to ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

WASHINGTON, Aug 20 (Reuters) - Medical monitoring technology company Masimo (MASI.O), opens new tab sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...